These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1103241

  • 1. [Prevention of hyperacute active rejection of renal allografts in primates using F(ab')2 and adequate immunosuppression].
    Martins AC, Wren SF, Busch GJ, MacPherson SG, von Haefen U, Wilson RE.
    AMB Rev Assoc Med Bras; 1975 Sep; 21(9):259-64. PubMed ID: 1103241
    [No Abstract] [Full Text] [Related]

  • 2. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
    Wren SF, Martins AC, Von Haefen U, Busch GJ, Katske GE, Koppenheffer TL, Shaipanich T, Wilson RE.
    Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A clinical attempt to avoid hyperacute rejection by F (ab') 2 organ pretreatment.
    Ahlmén J, Gustafsson A, Claes G, Kaijser B, Svalander C, Gelin L.
    Scand J Urol Nephrol; 1974 Jul; (29 Suppl):51-2. PubMed ID: 781817
    [Abstract] [Full Text] [Related]

  • 5. Survival of canine renal allografts after treatment with polyspecific F(ab')2 fragments.
    Abouna GM, Garver FA, Kogure H, DeLong TG, Andres GA.
    Surg Forum; 1973 Jul; 24():318-20. PubMed ID: 4618655
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM, Sterioff S, Bias W.
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
    Habal MB, Carpenter CB, Kobayashi K, Bush GJ, Misra M, Birtch AG.
    Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment.
    Corman JL, Kashiwagi N, Porter KA, Andres G, Iwatsuki S, Putnam CW, Popovtzer M, Penn I, Starzl TE.
    Transplantation; 1973 Jul; 16(1):60-3. PubMed ID: 4576857
    [No Abstract] [Full Text] [Related]

  • 13. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF, Stickel DL, Gunnells JC, McCoy R, Ward FE, Anderson EE, Amos DB.
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.
    Holter AR, McKearn TJ, Neu MR, Stuart FP.
    Surg Forum; 1972 Dec; 23(0):280-1. PubMed ID: 4601088
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.
    Holter AR, Neu MR, McKearn TJ, Lynch AF, Stuart FP.
    Transplant Proc; 1973 Mar; 5(1):593-6. PubMed ID: 4121180
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.